{"count": 1, "results": [{"_id": "21595121", "pmid": 21595121, "title": "Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations: Final Original Report", "journal": "", "authors": ["Jonas D", "Van Scoyoc E", "Gerrald K", "Wines R", "Amick H", "Triplette M", "Runge T"], "date": "2011-02-01T00:00:00Z", "meta_date_publication": "2011 Feb", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50021.652, "text_hl": "Rates of @<m>DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions</m> @DISEASE_MESH:D064420 @@@gastrointestinal side effects@@@ were higher with @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@exenatide@@@ and liraglutide than with comparators. ", "citations": {"NLM": "Jonas D, Van Scoyoc E, Gerrald K, Wines R, Amick H, Triplette M, Runge T. Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations: Final Original Report . 2011 Feb;():. PMID: 21595121", "BibTeX": "@article{21595121, title={Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations: Final Original Report}, author={Jonas D and Van Scoyoc E and Gerrald K and Wines R and Amick H and Triplette M and Runge T}}"}}]}